January 4th, 2018
•This protocol studies the role of chemokine (C-C motif) ligand 5 (CCL5) in the hypothalamus by delivering an antagonist, MetCCL5, into the mouse brain using a micro-osmotic pump brain infusion system. This transient inhibition of CCL5 activity interrupted hypothalamic insulin signaling, leading to glucose intolerance and peripheral systemic insulin sensitivity.
Tags
Related Videos
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Image-guided Convection-enhanced Delivery into Agarose Gel Models of the Brain
Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Transplantation Into the Mouse Ovarian Fat Pad
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery
A Drosophila In Vivo Injury Model for Studying Neuroregeneration in the Peripheral and Central Nervous System
Copyright © 2024 MyJoVE Corporation. 판권 소유